Health CanadaGeneral Alert
Gilenya (fingolimod): MS drug under Health Canada review in light of serious adv...
Published: January 1, 2012Recall ID: 23016Category: generalCountry: Canada
Product Description & Identification
Gilenya (fingolimod): MS drug under Health Canada review in light of serious adverse events
Additional Source Details
| Field | Value |
|---|---|
| N I D | 23016 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/gilenya-fingolimod-ms-drug-under-health-canada-review-light-serious-adverse-events-0 |
| Title | Gilenya (fingolimod): MS drug under Health Canada review in light of serious adverse events |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2012-01-01 |
| Organization | Communications and Public Affairs Branch |